Circulating mir-21 and mir-146a are associated with increased cytokines and CD36 in Algerian obese male participants

References

• Agrawal, S., et al., 2011. Leptin activates human B cells to secrete TNF-α, IL-6, and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 signaling pathway. Journal of clinical immunology, 31 (3), 472–478.
   PubMed Web of Science ®Google Scholar
• Balasubramanyam, M., et al., 2011. Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes. Molecular and cellular biochemistry, 351 (1–2), 197–205.
   PubMed Web of Science ®Google Scholar
• Baldassarre, A., et al., 2017. Circulating microRNAs and Bioinformatics Tools to Discover Novel Diagnostic Biomarkers of Pediatric Diseases. Genes (genes), 8 (9), 234.
   Web of Science ®Google Scholar
• Bhaumik, D., et al., 2009. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging, 1 (4), 402–411.
   PubMedGoogle Scholar
• Boldin, M.P., et al., 2011. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. The journal of experimental medicine, 208 (6), 1189–1201.
   PubMed Web of Science ®Google Scholar
• Derosa, G., et al., 2013. Adipocytokine levels in obese and non-obese subjects: an observational study. Inflammation, 36 (4), 914–920.
   PubMed Web of Science ®Google Scholar
• Fabian, M.R., Sonenberg, N., and Filipowicz, W., 2010. Regulation of mRNA translation and stability by microRNAs. Annual review of biochemistry, 79, 351–379.
   PubMed Web of Science ®Google Scholar
• Gao, X., Salomon, C., and Freeman, D.J., 2017. Extracellular vesicles from adipose tissue-A potential role in obesity and type 2 diabetes? Frontiers in endocrinology, 8, 202.
   PubMed Web of Science ®Google Scholar
• Ghorbani, S., et al., 2018. Decreased serum microRNA-21 level is associated with obesity in healthy and type 2 diabetic subjects. Archives of physiology and biochemistry, 124 (4), 300–305.
   PubMed Web of Science ®Google Scholar
• Glatz, J.F., et al., 2013. CD36 as a target to prevent cardiac lipotoxicity and insulin resistance. Prostaglandins, leukotrienes, and essential fatty acids, 88 (1), 71–77.
   PubMed Web of Science ®Google Scholar
• Grzegorczyk, E.A., et al., 2018. Lack of pronounced changes in the expression of fatty acid handling proteins in adipose tissue and plasma of morbidly obese humans. Nutrition & diabetes, 8 (1), 3.
   PubMedGoogle Scholar
• Harford, K.A., et al., 2011. Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue. The proceedings of the nutrition society, 70 (4), 408–417.
   PubMed Web of Science ®Google Scholar
• Hector, J., et al., 2007. TNF-alpha alters visfatin and adiponectin levels in human fat. Hormone and metabolic research, 39 (4), 250–255.
   PubMed Web of Science ®Google Scholar
• Iliopoulos, D., et al., 2010. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Molecular cell, 39 (4), 493–506.
   PubMed Web of Science ®Google Scholar
• Kang, Y.E., et al., 2016. The roles of adipokines, proinflammatory cytokines, and adipose tissue macrophages in obesity-associated insulin resistance in modest obesity and early metabolic dysfunction. PLoS One, 11 (4), e0154003.
   PubMed Web of Science ®Google Scholar
• Kennedy, D.J., and Kashyap, S.R., 2011. Pathogenic role of scavenger receptor CD36 in the metabolic syndrome and diabetes. Metabolic syndrome and related disorders, 9 (4), 239–245.
   PubMed Web of Science ®Google Scholar
• Kleinridders, A., et al., 2009. MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell metabolism, 10 (4), 249–259.
   PubMed Web of Science ®Google Scholar
• Kong, L., et al., 2011. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta diabetologica, 48 (1), 61–69.
   PubMed Web of Science ®Google Scholar
• Ling, H.Y., et al., 2012. MiRNA-21 reverses high glucose and high insulin induced insulin resistance in 3T3-L1 adipocytes through targeting phosphatase and tensin homologue. Experimental and clinical endocrinology & diabetes, 120 (9), 553–559.
   PubMed Web of Science ®Google Scholar
• Marquez, R.T., et al., 2010. MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-kappaB signaling. American journal of physiology. gastrointestinal and liver physiology, 298 (4), G535–G541.
   PubMed Web of Science ®Google Scholar
• Martius, G., et al., 2015. The anti-TNF-α antibody infliximab inhibits the expression of fat-transporter-protein FAT/CD36 in a selective hepatic-radiation mouse model. International journal of molecular sciences, 16 (3), 4682–4697.
   PubMed Web of Science ®Google Scholar
• Mazloom, H., et al., 2016. Decreased expression of microRNA-21 is associated with increased cytokine production in peripheral blood mononuclear cells (PBMCs) of obese type 2 diabetic and non-diabetic subjects. Molecular and cellular biochemistry, 419 (1-2), 11–17.
   PubMed Web of Science ®Google Scholar
• Meldrum, D.R., Morris, M.A., and Gambone, J.C., 2017. Obesity pandemic: causes, consequences, and solutions-but do we have the will? Fertility and sterility, 107 (4), 833–839.
   PubMed Web of Science ®Google Scholar
• Nadira, F., et al., 2016. Prevalence of obesity in an Algerian adult population. Endocrine abstracts, 41, EP815.
   Google Scholar
• Nayak, B.S., et al., 2010. Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians. Primary care diabetes, 4 (3), 187–192.
   PubMed Web of Science ®Google Scholar
• Osmai, M., et al., 2016. MicroRNAs as regulators of beta-cell function and dysfunction. Diabetes/metabolism research and reviews, 32 (4), 334–349.
   PubMed Web of Science ®Google Scholar
• Pauley, K.M., et al., 2008. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis research & therapy, 10 (4), R101.
   PubMed Web of Science ®Google Scholar
• Pawlak, M., Lefebvre, P., and Staels, B., 2015. Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. Journal of hepatology, 62 (3), 720–733.
   PubMed Web of Science ®Google Scholar
• Sopasakis, V.R., et al., 2004. High Local Concentrations and Effects on Differentiation Implicate interleukin-6 as a paracrine regulator. Obesity research, 12 (3), 454–460.
   PubMedGoogle Scholar
• Sun, Y., et al., 2010. Increased CD36 expression signals monocyte activation among patients with type 2 diabetes. Diabetes care, 33 (9), 2065–2067.
   PubMed Web of Science ®Google Scholar
• Thorand, B., et al., 2010. Associations between leptin and the leptin / adiponectin ratio and incident Type 2 diabetes in middle-aged men and women: results from the MONICA / KORA Augsburg study 1984-2002. Diabetic medicine, 27 (9), 1004–1011.
   PubMed Web of Science ®Google Scholar
• Trujillo, M.E., and Scherer, P.E., 2006. Adipose tissue-derived factors: impact on health and disease. Endocrine reviews, 27 (7), 762–778.
   PubMed Web of Science ®Google Scholar
• Tseng, Y.-H., Cypess, A.M., and Kahn, C.R., 2010. Cellular bioenergetics as a target for obesity therapy. Nature reviews drug discovery, 9 (6), 465–482.
   PubMed Web of Science ®Google Scholar
• Turchinovich, A., et al., 2013. Circulating miRNAs: cell-cell communication function? Frontiers in Genetics, 4, 119.
   PubMedGoogle Scholar
• Weisberg, S.P., et al., 2003. Obesity is associated with macrophage accumulation in adipose tissue. The journal of clinical investigation, 112 (12), 1796–1808.
   PubMed Web of Science ®Google Scholar
• WHO (World Health Organization) 2016. Obesity and overweight [Internet]. Fact sheet, 311.
   Google Scholar
• Wu, H., et al., 2014. The role of microRNAs in diabetic nephropathy. Journal of diabetes research, 2014, 920134.
   PubMed Web of Science ®Google Scholar
• Ying, W., et al., 2017. Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity. Cell, 171 (2), 372–384.e312.
   PubMed Web of Science ®Google Scholar
• Zhang, X., et al., 2008. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell, 135 (1), 61–73.
   PubMed Web of Science ®Google Scholar
• Zhou, J., et al., 2011. MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proceedings of the national academy of sciences of the United States of America, 108 (25), 10355–10360.
   PubMed Web of Science ®Google Scholar